3'4'7-Trihydroxyflavone inhibits RANKL-induced osteoclast formation via NFATc1
Ju‐Hee Kang(National Cancer Center), Mijung Yim(Sookmyung Women's University)
Cited by 4
Related Papers
Renal cell carcinoma escapes death by p53 depletion through transglutaminase 2-chaperoned autophagy
|Cell Death and Disease|2016|70
Phosphodiesterase inhibitors stimulate osteoclast formation via TRANCE/RANKL expression in osteoblasts: possible involvement of ERK and p38 MAPK pathways
|FEBS Letters|2005|68
Involvement of Cox-2 in the metastatic potential of chemotherapy-resistant breast cancer cells
|BMC Cancer|2011|53
PDE4 inhibitor upregulates PTH‐induced osteoclast formation via CRE‐mediated <i>COX‐2</i> expression in osteoblasts
|FEBS Letters|2009|13
Cetylpyridinium Chloride Inhibits Receptor Activator of Nuclear Factor-κB Ligand-Induced Osteoclast Formation
|Biological and Pharmaceutical Bulletin|2013|11